rs148233131

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003060.4(SLC22A5):​c.1590G>T​(p.Met530Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000616 in 1,610,010 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M530V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00036 ( 3 hom. )

Consequence

SLC22A5
NM_003060.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.323

Publications

5 publications found
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A5 Gene-Disease associations (from GenCC):
  • systemic primary carnitine deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet, G2P, ClinGen
  • short QT syndrome
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0060786307).
BP6
Variant 5-132394188-G-T is Benign according to our data. Variant chr5-132394188-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 460403.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00311 (473/152260) while in subpopulation AFR AF = 0.0108 (448/41546). AF 95% confidence interval is 0.00996. There are 2 homozygotes in GnomAd4. There are 224 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003060.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC22A5
NM_003060.4
MANE Select
c.1590G>Tp.Met530Ile
missense
Exon 10 of 10NP_003051.1O76082-1
SLC22A5
NM_001308122.2
c.1662G>Tp.Met554Ile
missense
Exon 11 of 11NP_001295051.1O76082-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC22A5
ENST00000245407.8
TSL:1 MANE Select
c.1590G>Tp.Met530Ile
missense
Exon 10 of 10ENSP00000245407.3O76082-1
SLC22A5
ENST00000435065.7
TSL:1
c.1662G>Tp.Met554Ile
missense
Exon 11 of 11ENSP00000402760.2O76082-3
SLC22A5
ENST00000448810.6
TSL:1
n.*442G>T
non_coding_transcript_exon
Exon 10 of 10ENSP00000401860.2H7C1R8

Frequencies

GnomAD3 genomes
AF:
0.00309
AC:
470
AN:
152142
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0107
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000931
AC:
234
AN:
251386
AF XY:
0.000596
show subpopulations
Gnomad AFR exome
AF:
0.0114
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000355
AC:
518
AN:
1457750
Hom.:
3
Cov.:
30
AF XY:
0.000296
AC XY:
215
AN XY:
725492
show subpopulations
African (AFR)
AF:
0.0108
AC:
362
AN:
33384
American (AMR)
AF:
0.000962
AC:
43
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86188
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000514
AC:
57
AN:
1108252
Other (OTH)
AF:
0.000830
AC:
50
AN:
60230
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
24
47
71
94
118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00311
AC:
473
AN:
152260
Hom.:
2
Cov.:
32
AF XY:
0.00301
AC XY:
224
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0108
AC:
448
AN:
41546
American (AMR)
AF:
0.00111
AC:
17
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68004
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00137
Hom.:
4
Bravo
AF:
0.00381
ESP6500AA
AF:
0.0129
AC:
57
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00119
AC:
145
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Renal carnitine transport defect (3)
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
3.7
DANN
Benign
0.41
DEOGEN2
Benign
0.069
T
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.80
FATHMM_MKL
Benign
0.43
N
LIST_S2
Benign
0.48
T
MetaRNN
Benign
0.0061
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.32
PrimateAI
Benign
0.41
T
PROVEAN
Benign
0.060
N
REVEL
Benign
0.075
Sift
Benign
0.59
T
Sift4G
Benign
0.49
T
Polyphen
0.0
B
Vest4
0.10
MutPred
0.22
Gain of methylation at K531 (P = 0.0202)
MVP
0.62
MPC
0.23
ClinPred
0.0031
T
GERP RS
0.00076
Varity_R
0.049
gMVP
0.33
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148233131; hg19: chr5-131729880; API